Bill
H 1313
Overview: H 1313, "An Act relating to patient choice in dispensing of clinician-administered drugs", is scheduled for a hearing on 10/01/2025. The bill was introduced on February 2
Overview: H 1313, "An Act relating to patient choice in dispensing of clinician-administered drugs", is scheduled for a hearing on 10/01/2025. The bill was introduced on February 27, 2025.
Purpose and Intent: The intent of this bill is to expand patient choice and control over the dispensing of clinician-administered drugs, such as those administered in a physician's office or hospital setting.
Key Provisions:
- Requires health insurers to allow patients to choose whether to have clinician-administered drugs dispensed by the clinician or by a pharmacy of the patient's choice
- Prohibits health insurers from imposing higher cost-sharing or other penalties on patients who choose to have drugs dispensed by a pharmacy
- Mandates that clinicians provide patients with a written notice of their right to choose the dispensing location
Affected Parties and Impacts:
- Patients receiving clinician-administered drugs will have greater flexibility and control over where those drugs are dispensed
- Health insurers will be required to adjust their policies and coverage to accommodate patient choice in drug dispensing
Procedural and Timeline Considerations:
The bill is currently scheduled for a hearing on 10/01/2025. If passed, the new patient choice requirements would take effect at the start of the next plan year.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
